Covidien Announces Share Repurchase Program of up to $2B

Covidien plc COV today announced that its Board of Directors has authorized a program to purchase up to $2 billion of the Company's ordinary shares from time to time, based on market conditions. In the twelve months ending June 2011, Covidien has returned more than $1 billion to shareholders in dividends and share repurchases, representing more than 50% of its free cash flow. This is well above the Company's stated annual goal of returning 25% to 40% of free cash flow to shareholders.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsBuybacksHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!